Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy (Q44079553)

29 November 2017

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy (English)

1 reference

Adaptive radiation therapy

29 November 2017

0 references

1 reference

1 reference

1

Johan Bussink

1 reference

29 November 2017

Michael R L Stratford

2

1 reference

29 November 2017

Albert J van der Kogel

3

1 reference

29 November 2017

Lisa K Folkes

4

1 reference

29 November 2017

Johannes H A M Kaanders

5

1 reference

29 November 2017

1 June 2002

1 reference

Radiotherapy and Oncology

29 November 2017

1 reference

29 November 2017

63

1 reference

29 November 2017

3

1 reference

29 November 2017

285-291

1 reference

Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Nicotinamide pharmacokinetics in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Tumor hypoxia in pelvic recurrences of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Overcoming tumour radiation resistance resulting from acute hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Administration of nicotinamide during chart: Pharmacokinetics, dose escalation, and clinical toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

ARCON: experience in 215 patients with advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900072-5

7 January 2021

10.1016/S0167-8140(02)00072-5

Identifiers

DOI

1 reference

29 November 2017

1 reference